Literature DB >> 20592220

Selective reduction of cholecystokinin-positive basket cell innervation in a model of temporal lobe epilepsy.

Megan S Wyeth1, Nianhui Zhang, Istvan Mody, Carolyn R Houser.   

Abstract

Perisomatic inhibition from basket cells plays an important role in regulating pyramidal cell output. Two major subclasses of CA1 basket cells can be identified based on their expression of either cholecystokinin (CCK) or parvalbumin. This study examined their fates in the mouse pilocarpine model of temporal lobe epilepsy. Overall, immunohistochemical labeling of GABAergic boutons in the pyramidal cell layer of CA1 was preserved in the mouse model. However, CCK-labeled boutons in this layer were chronically reduced, whereas parvalbumin-containing boutons were conserved. Immunohistochemistry for cannabinoid receptor 1 (CB(1)), another marker for CCK-containing basket cells, also labeled fewer boutons in pilocarpine-treated mice. Hours after status epilepticus, electron microscopy revealed dark degenerating terminals in the pyramidal cell layer with lingering CCK and CB(1) immunoreactivity. In mice with recurrent seizures, carbachol-induced enhancement of spontaneous IPSCs (sIPSCs) originating from CCK-containing basket cells was accordingly reduced in CA1 pyramidal cells. By suppressing sIPSCs from CCK-expressing basket cells, a CB(1) agonist reverted the stimulatory effects of carbachol in naive mice to levels comparable with those observed in cells from epileptic mice. The agatoxin-sensitive component of CA1 pyramidal cell sIPSCs from parvalbumin-containing interneurons was increased in pilocarpine-treated mice, and miniature IPSCs were reduced, paralleling the decrease in CCK-labeled terminals. Altogether, the findings are consistent with selective reduction in perisomatic CA1 pyramidal cell innervation from CCK-expressing basket cells in mice with spontaneous seizures and a greater reliance on persisting parvalbumin innervation. This differential alteration in inhibition may contribute to the vulnerability of the network to seizure activity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20592220      PMCID: PMC3319326          DOI: 10.1523/JNEUROSCI.1183-10.2010

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  71 in total

1.  Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations.

Authors:  N Hájos; I Katona; S S Naiem; K MacKie; C Ledent; I Mody; T F Freund
Journal:  Eur J Neurosci       Date:  2000-09       Impact factor: 3.386

Review 2.  Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks.

Authors:  Marlene Bartos; Imre Vida; Peter Jonas
Journal:  Nat Rev Neurosci       Date:  2007-01       Impact factor: 34.870

3.  Molecular composition of the endocannabinoid system at glutamatergic synapses.

Authors:  István Katona; Gabriella M Urbán; Matthew Wallace; Catherine Ledent; Kwang-Mook Jung; Daniele Piomelli; Ken Mackie; Tamás F Freund
Journal:  J Neurosci       Date:  2006-05-24       Impact factor: 6.167

4.  Dendritic but not somatic GABAergic inhibition is decreased in experimental epilepsy.

Authors:  R Cossart; C Dinocourt; J C Hirsch; A Merchan-Perez; J De Felipe; Y Ben-Ari; M Esclapez; C Bernard
Journal:  Nat Neurosci       Date:  2001-01       Impact factor: 24.884

5.  Vulnerability and plasticity of the GABA system in the pilocarpine model of spontaneous recurrent seizures.

Authors:  C R Houser; M Esclapez
Journal:  Epilepsy Res       Date:  1996-12       Impact factor: 3.045

6.  Brain-state- and cell-type-specific firing of hippocampal interneurons in vivo.

Authors:  Thomas Klausberger; Peter J Magill; László F Márton; J David B Roberts; Philip M Cobden; György Buzsáki; Peter Somogyi
Journal:  Nature       Date:  2003-02-20       Impact factor: 49.962

7.  Downregulation of the CB1 cannabinoid receptor and related molecular elements of the endocannabinoid system in epileptic human hippocampus.

Authors:  Anikó Ludányi; Loránd Eross; Sándor Czirják; János Vajda; Péter Halász; Masahiko Watanabe; Miklós Palkovits; Zsófia Maglóczky; Tamás F Freund; István Katona
Journal:  J Neurosci       Date:  2008-03-19       Impact factor: 6.167

Review 8.  Neuronal diversity and temporal dynamics: the unity of hippocampal circuit operations.

Authors:  Thomas Klausberger; Peter Somogyi
Journal:  Science       Date:  2008-07-04       Impact factor: 47.728

9.  Cholecystokinin inhibits endocannabinoid-sensitive hippocampal IPSPs and stimulates others.

Authors:  Miranda A Karson; Kevin C Whittington; Bradley E Alger
Journal:  Neuropharmacology       Date:  2007-07-01       Impact factor: 5.250

10.  CB1 cannabinoid receptor activity is modulated by the cannabinoid receptor interacting protein CRIP 1a.

Authors:  Jason L Niehaus; Yunguang Liu; Kathleen T Wallis; Michaela Egertová; Sheela G Bhartur; Somnath Mukhopadhyay; Shanping Shi; Hengjun He; Dana E Selley; Allyn C Howlett; Maurice R Elphick; Deborah L Lewis
Journal:  Mol Pharmacol       Date:  2007-09-25       Impact factor: 4.436

View more
  52 in total

1.  Statistical parametric mapping reveals regional alterations in cannabinoid CB1 receptor distribution and G-protein activation in the 3D reconstructed epileptic rat brain.

Authors:  Katherine W Sayers; Peter T Nguyen; Robert E Blair; Laura J Sim-Selley; Robert J DeLorenzo
Journal:  Epilepsia       Date:  2012-04-17       Impact factor: 5.864

2.  Synapsin II Regulation of GABAergic Synaptic Transmission Is Dependent on Interneuron Subtype.

Authors:  Pedro Feliciano; Heidi Matos; Rodrigo Andrade; Maria Bykhovskaia
Journal:  J Neurosci       Date:  2017-01-13       Impact factor: 6.167

3.  Functional Reduction in Cannabinoid-Sensitive Heterotypic Inhibition of Dentate Basket Cells in Epilepsy: Impact on Network Rhythms.

Authors:  Jiandong Yu; Archana Proddutur; Bogumila Swietek; Fatima S Elgammal; Vijayalakshmi Santhakumar
Journal:  Cereb Cortex       Date:  2015-09-22       Impact factor: 5.357

Review 4.  From Molecular Circuit Dysfunction to Disease: Case Studies in Epilepsy, Traumatic Brain Injury, and Alzheimer's Disease.

Authors:  Chris G Dulla; Douglas A Coulter; Jokubas Ziburkus
Journal:  Neuroscientist       Date:  2015-05-06       Impact factor: 7.519

Review 5.  Organization and control of epileptic circuits in temporal lobe epilepsy.

Authors:  A Alexander; M Maroso; I Soltesz
Journal:  Prog Brain Res       Date:  2016-06-07       Impact factor: 2.453

6.  Loss of cholecystokinin-containing terminals in temporal lobe epilepsy.

Authors:  Chengsan Sun; Jianli Sun; Alev Erisir; Jaideep Kapur
Journal:  Neurobiol Dis       Date:  2013-09-17       Impact factor: 5.996

7.  Structural alterations in fast-spiking GABAergic interneurons in a model of posttraumatic neocortical epileptogenesis.

Authors:  Feng Gu; Isabel Parada; Fran Shen; Judith Li; Alberto Bacci; Kevin Graber; Reza Moein Taghavi; Karina Scalise; Philip Schwartzkroin; Jurgen Wenzel; David A Prince
Journal:  Neurobiol Dis       Date:  2017-08-18       Impact factor: 5.996

Review 8.  Hippocampal GABAergic Inhibitory Interneurons.

Authors:  Kenneth A Pelkey; Ramesh Chittajallu; Michael T Craig; Ludovic Tricoire; Jason C Wester; Chris J McBain
Journal:  Physiol Rev       Date:  2017-10-01       Impact factor: 37.312

Review 9.  Cannabinoids and Epilepsy.

Authors:  Evan C Rosenberg; Richard W Tsien; Benjamin J Whalley; Orrin Devinsky
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

Review 10.  Quantitative assessment of CA1 local circuits: knowledge base for interneuron-pyramidal cell connectivity.

Authors:  Marianne J Bezaire; Ivan Soltesz
Journal:  Hippocampus       Date:  2013-07-10       Impact factor: 3.899

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.